Article Details
Retrieved on: 2025-03-05 21:55:46
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Invivyd's monoclonal antibody, pemivibart, which neutralizes COVID-19 variants effectively. It's crucial for immunocompromised individuals, especially given the limited efficacy of COVID vaccines, highlighting ongoing efforts against evolving variants like Omicron.
Article found on: www.contagionlive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here